Are you ready to shape the benefit–risk strategy for breakthrough oncology medicines and turn complex data into decisions that protect patients?
In this Barcelona-based role, you will be a key voice in advancing safe, effective treatments by steering proactive pharmacovigilance and risk management across development and post-marketing. Your work will directly influence how quickly and confidently our therapies reach those who need them most. Reporting to senior leaders in Patient Safety and working shoulder-to-shoulder with Safety Physicians and PV Scientists, you will drive the evaluation and communication of emerging safety signals, author high-impact safety documents, and engage with critical governance forums. Can you see yourself leading clear, evidence-based recommendations that guide integral teams and regulators? This is your opportunity to bring scientific rigour and decisive leadership to areas where precision and pace matter most.
Accountabilities
- Safety Strategy Leadership: Lead proactive pharmacovigilance and risk management planning for designated products,
owning the safety aspects of global risk management plans to clarify benefit–risk and protect patients.
- Cross-Functional Representation: Represent Patient Safety on project teams across development and marketed portfolios, shaping program strategy with data-driven safety perspectives that accelerate high-quality decisions.
- Signal Detection and Risk Evaluation: Review safety data from clinical trials, post-marketing, literature, and epidemiology to identify and characterise risks; translate findings into clear conclusions and actions.
- Governance and Committee Engagement: Present issues to the Safety Information Review Committee and lead data evaluation discussions; perform duties on the Safety Strategy and Management Team to ensure robust oversight.
- Regulatory Safety Deliverables: Author or provide strategic input into periodic safety documents (PBRERs, PSURs, DSURs) to agreed timelines, ensu